Please login to the form below

Not currently logged in
Email:
Password:

Ibuprofen could reduce Parkinson's risk

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

Regular use of OTC NSAIDs was associated with a 60 per cent reduction in the risk of developing Parkinson's disease, compared with occasional or non-use.

The study compared the use of aspirin and other NSAIDs in 579 men and women, half of whom had Parkinson's disease. Regular NSAID use was defined as taking two or more tablets a week for at least one month. Regular use of aspirin was associated with a 40 per cent reduction in risk, but only among women.

"Our findings suggest NSAIDs are protective against Parkinson's disease, with a particularly strong effect among regular users of non-aspirin NSAIDs, especially those who reported two or more years of use," commented study author Dr Anelika Wahner of the UCLA School of Public Health in Los Angeles.

The results are published in full in the 6 November 2007 issue of Neurology, the medical journal of the American Academy of Neurology.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics